Yoav H Messinger MD
Pediatric Hematologist/Oncologist Children's Hospitals of Minnesota
Join to View Full Profile
2530 Chicago AveMinneapolis, MN 55404
Dr. Messinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1993 - 1996- University of MinnesotaResidency, Pediatrics, 1991 - 1993
Tel Aviv University SacklerClass of 1985
Certifications & Licensure
MN State Medical License 1993 - 2025
WI State Medical License 2011 - 2023
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2006 Aug 04
- Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome Start of enrollment: 2005 Mar 01
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries.Anne K Harris, Alexander T Nelson, Dave Watson, Paige H R Mallinger, Yoav H Messinger
Cancer. 2025-05-01 - Prognostic Significance of GermlinePathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor.Alexander T Nelson, Dave Watson, Kenneth S Chen, Damon R Olson, Jennifer N Stall
JCO Precision Oncology. 2025-04-01 - Bloodstream Infections in Childhood Acute Myeloid Leukemia and Machine Learning Models: A Single-institutional Analysis.Taylor L Chappell, Ellen G Pflaster, Resty Namata, Jometa Bell, Lane H Miller
Journal of Pediatric Hematology/oncology. 2025-01-01
Press Mentions
Triplet Regimen Active Against Relapsed/Refractory Pediatric AMLOctober 24th, 2017
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
